By Josh White
Date: Tuesday 27 Feb 2024
(Sharecast News) - Healthcare services company Uniphar reported a robust set of preliminary results on Tuesday, with EBITDA rising 17.7%, as it achieved a return on capital employed of 15.2% and maintained year-end leverage at 1.6x.
By Josh White
Date: Tuesday 30 Jan 2024
(Sharecast News) - Pharmaceutical and medical technology service company Uniphar said in an update on Tuesday that its performance in 2023 met its own expectations in terms of gross profit and EBITDA, while also achieving normalised free cash flow conversion in line with medium-term guidance.
By Josh White
Date: Thursday 14 Sep 2023
(Sharecast News) - Healthcare services company Uniphar reported gross profit growth of 28.6% in its first half on Thursday, of which 5.5% was organic, representing progress across all divisions.
Currency | UK Pounds |
Share Price | 223.00p |
Change Today | 3.00p |
% Change | 1.36 % |
52 Week High | 300.00 |
52 Week Low | 180.00 |
Volume | 463 |
Shares Issued | 273.02m |
Market Cap | £608.82m |
RiskGrade | 192 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 18-Apr-24 | 28-Sep-23 |
Paid | 14-May-24 | 20-Oct-23 |
Amount | 1.19¢ | 0.64¢ |
Time | Volume / Share Price |
15:58 | 448 @ 223.05p |
08:05 | 15 @ 223.00p |
CEO | Gerard Rabbette |
CFO | Timothy Dolphin |
You are here: research